Solara Active Pharma Sciences Limited (BOM:890202)

BOM:890202 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	22,941	13,353	11,787	23,977	50,056	11,939
Market Cap Growth	150.91%	13.28%	-50.84%	-52.10%	319.28%	10.69%
Enterprise Value	31,066	23,165	21,509	31,550	53,179	14,259
PE Ratio	4248.24	-	-	-	22.61	10.42
PS Ratio	1.78	1.04	0.82	1.89	3.10	0.90
PB Ratio	2.09	1.43	0.79	1.57	3.14	1.10
P/TBV Ratio	3.28	2.54	1.09	2.20	4.38	1.90
P/FCF Ratio	13.27	19.69	26.23	-	-	-
P/OCF Ratio	10.78	12.27	7.54	-	32.20	4.93
EV/Sales Ratio	2.40	1.80	1.49	2.49	3.29	1.08
EV/EBITDA Ratio	14.48	-	16.36	39.77	13.73	5.45
EV/EBIT Ratio	26.93	-	77.96	-	18.68	8.23
EV/FCF Ratio	17.97	34.16	47.86	-	-	-
Debt / Equity Ratio	0.77	1.00	0.67	0.68	0.39	0.66
Debt / EBITDA Ratio	4.96	-	7.55	12.63	1.59	2.73
Debt / FCF Ratio	-	13.84	22.54	-	-	-
Asset Turnover	-	0.49	0.49	0.46	0.68	0.64
Inventory Turnover	-	1.88	1.48	1.63	2.68	2.53
Quick Ratio	-	0.33	0.53	0.56	0.94	0.43
Current Ratio	-	0.64	1.08	1.17	1.34	0.92
Return on Equity (ROE)	-	-46.49%	-1.47%	-3.74%	16.50%	11.17%
Return on Assets (ROA)	-	-4.70%	0.59%	-0.58%	7.46%	5.26%
Return on Capital (ROIC)	2.04%	-5.62%	0.68%	-0.68%	8.84%	6.54%
Return on Capital Employed (ROCE)	-	-	1.50%	-	15.60%	12.20%
Earnings Yield	0.02%	-42.49%	-1.88%	-2.43%	4.42%	9.60%
FCF Yield	7.54%	5.08%	3.81%	-18.80%	-0.38%	-2.24%
Payout Ratio	-	-	-	-	8.91%	13.63%
Buyback Yield / Dilution	28.14%	0.00%	-0.15%	-4.75%	-28.19%	-8.24%

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.